Attana – Cell interactions is our passion

Our cutting edge biosensor technology provides you with advantages when developing new pharmaceuticals.

We offer you a contract research process enabled by our proven technology and a team of highly experienced application specialists. We select the best candidates to maximize your operations.

Our third generation biosensors technology is unique and patented and reduces animal testing and makes the drug development process more efficient and cost effective.

Swedish press releases including regulatory releases are available in our Swedish news room. The English newsroom can be found here.

Attana receives first payment of 300.000 SEK for joint research project with Karolinska Universitetssjukhuset and KTH
In November 2017 Attana AB, Karolinska Universitetssjukhuset and KTH, Royal Institute of Technology was granted 4.8 MSEK from Vinnova. The grant is for development of bispecific antibodies targeting […]
Attana participates at DDIP 2018, Drug Discovery Innovation Programme, Frankfurt November 29-30, 2018
The DDIP-conference focus on new technologies for improved drug development. At the conference leading professionals within industry and academy will participate. Attana will present at the […]
New publication using Attana’s QCM-technology for optimization of biosensor surfaces using different flow types
Researchers at the University of Chemical Technology and Metallurgy, Bulgaria and Sofia University have with Attana’s QCM-technology investigated the effect of different process parameters when […]

2018

November 29 to 30 - DDIP

Attana is presenting new technologies for improved drug development at the Drug Discovery Innovation Programme, Frankfurt November 29-30, 2018. Welcome to listen or contact us for more information.

Contact: info@attana.com

Greta Arwidssons v. 21, 114 19 Stockholm, Sweden.

Subscribe for information

Privacy statement | Terms of use